Related Experiment Video
Updated: Aug 8, 2026
11:15
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Germline TP53 mutations and Li-Fraumeni syndrome
1Paterson Institute for Cancer Research, Christie NHS Trust, Manchester, UK. jvarley@picr.man.ac.uk
Human Mutation
|March 6, 2003
Summary
Germline TP53 (p53) mutations are linked to Li-Fraumeni syndrome. This review details mutation types, associated tumors, and clinical challenges for TP53 germline mutations.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- TP53 (p53) gene mutations are implicated in numerous cancers.
- Germline mutations in TP53 are associated with Li-Fraumeni syndrome (LFS) and Li-Fraumeni-like syndrome (LFL).
- Over 250 independent germline TP53 mutations have been reported in scientific literature.
Purpose of the Study:
- To review the spectrum of germline TP53 mutations.
- To analyze genotype-phenotype correlations based on detailed pedigree analysis.
- To discuss tumors associated with germline TP53 mutations and related clinical/ethical issues.
Main Methods:
- Literature review of published reports on germline TP53 mutations.
- Analysis of genotype-phenotype correlations from patient pedigrees.
- Discussion of mutation detection methods and tumor spectrum.
Main Results:
- The spectrum of germline TP53 mutations largely mirrors somatic mutations found in tumors, with some exceptions.
- Detailed pedigree analysis aids in understanding tumor predisposition.
- Various tumor types are associated with inherited TP53 mutations.
Conclusions:
- Germline TP53 mutations confer a significant risk for various cancers, characteristic of LFS/LFL.
- Understanding mutation patterns is crucial for genetic counseling and clinical management.
- Ethical and clinical considerations are paramount for individuals with germline TP53 mutations.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...